ENDS Toxicity / Carcinogenic: Difference between revisions

ENDS Toxicity / Carcinogenic (view source)

465 bytes removed , 2 months ago

no edit summary

5,382

edits

@@ Line 275: / Line 275: @@
 *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110871/pdf/10.1177_2042098614524430.pdf PDF Version]
 *Citation: Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014 Apr;5(2):67-86. doi: 10.1177/2042098614524430. PMID: 25083263; PMCID: PMC4110871.
-*Acknowledegement: Riccardo Polosa is a Professor of Medicine and is supported by the University of Catania, Italy. He has received lecture fees and research funding from GlaxoSmithKline and Pfizer, manufacturers of stop smoking medications. He has also served as a consultant for Pfizer and Arbi Group Srl (Milano, Italy), the distributor of Categoria™ e-Cigarettes. His research on electronic cigarettes is currently supported by LIAF (Lega Italiana AntiFumo).
 ===2014 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154473/ Levels of selected carcinogens and toxicants in vapor from electronic cigarettes]=== <!--T:55-->